Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AMGEN INC v. SANDOZ INC.
Case Number:
3:18-cv-11026
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Benesch
- Blank Rome
- Covington & Burling
- Epstein Becker
- FisherBroyles
- Flaster Greenberg
- Gibbons PC
- Hill Wallack
- Jones Day
- Kramer Alberti
- Martin Clearwater
- Rivkin Radler
- Saul Ewing
- Schnader Harrison
- Sills Cummis
- Stone Conroy LLC
- Troutman
- Walsh Pizzi
- Windels Marx
Companies
- Alkem Laboratories Ltd.
- Allergan PLC
- Amgen Inc.
- Amneal Pharmaceuticals Inc.
- Aurobindo Pharma Ltd.
- Avet Pharmaceuticals Inc.
- Celgene Corp.
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Hetero Labs Ltd.
- Macleods Pharmaceuticals Ltd.
- Mankind Pharma Ltd.
- Prinston Pharmaceutical Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Unichem Laboratories Ltd.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
September 20, 2021
Sandoz Infringed Amgen's Psoriasis Drug Patents, Court Says
A New Jersey federal judge on Monday found that Sandoz and Zydus Pharmaceuticals infringed several of Amgen's patents for its blockbuster plaque psoriasis medication Otezla, entering judgment in favor of Amgen on a trio of patents.
-
July 28, 2021
Amgen's Psoriasis Drug Patents Are Valid, NJ Court Told
Amgen Inc. urged a New Jersey federal court on Wednesday to find that Sandoz Inc. and Zydus Pharmaceuticals Inc. infringed patents for the blockbuster plaque psoriasis medication Otezla, wrapping up a trial in which the generic-drug makers said the formulas were too obvious to warrant patent protection.